ESC Premium Access

What is the latest randomized evidence in TAVI field.

Congress Presentation

About the speaker

Professor Andreas Baumbach

St Bartholomews and Queen Mary University, London (United Kingdom of Great Britain & Northern Ireland)
13 presentations

2 more presentations in this session

Is durability still an issue?

Speaker: Professor E. Durand (Rouen, FR)


NOAC, Vitamin K Antagonists, dual or single antiplatelet therapy after TAVI?

Speaker: Professor J. Mehilli (Landshut, DE)


Access the full session

Severe symptomatic aortic valve stenosis – TAVI the first treatment choice for all?

Speakers: Professor A. Baumbach, Professor E. Durand, Professor J. Mehilli

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb